Astrazeneca PLC Stock Ownership - Who owns Astrazeneca?

Open Broker Account

Insider buying vs selling

Have Astrazeneca PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AZN insiders and whales buy or sell their stock.

AZN Shareholders

What type of owners hold Astrazeneca PLC stock?
Price T Rowe Associates Inc5.55%85,919,796$4.69BInstitution
Wellington Management Group LLP3.12%48,297,922$2.64BInstitution
Primecap Management Co2.96%45,813,820$2.50BInstitution
Capital International Investors2.54%39,382,999$2.15BInstitution
Fmr LLC1.65%25,530,755$1.39BInstitution
Fisher Asset Management LLC1.38%21,387,732$1.17BInstitution
Gqg Partners LLC1.21%18,715,660$1.02BInstitution
Franklin Resources Inc1.10%17,096,147$933.11MInstitution
Blackrock Inc0.77%11,938,298$651.59MInstitution
Bank Of America Corp0.75%11,631,279$634.84MInstitution

1 of 3

AZN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMY75.93%0.33%Net SellingNet Selling
AMGN76.53%0.99%Net SellingNet Buying
MRK72.77%0.18%Net Selling

Astrazeneca Stock Ownership FAQ

Who owns Astrazeneca?

Astrazeneca (NASDAQ: AZN) is owned by 33.44% institutional shareholders, 0.00% Astrazeneca insiders, and 66.56% retail investors. Price T Rowe Associates Inc is the largest individual Astrazeneca shareholder, owning 85.92M shares representing 5.55% of the company. Price T Rowe Associates Inc's Astrazeneca shares are currently valued at $4.69B.

If you're new to stock investing, here's how to buy Astrazeneca stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.